Dr Ciro J Carafa, MD | |
120 S Main St, Lodi, NJ 07644-2204 | |
(973) 473-7870 | |
(973) 472-1455 |
Full Name | Dr Ciro J Carafa |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 47 Years |
Location | 120 S Main St, Lodi, New Jersey |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1154485449 | NPI | - | NPPES |
1254201 | Medicaid | NJ |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RR0500X | Internal Medicine - Rheumatology | MA40377 (New Jersey) | Secondary |
207R00000X | Internal Medicine | 25MA04037700 (New Jersey) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Amedisys Home Health | Hackensack, NJ | Home health agency |
Hackensack University Medical Center | Hackensack, NJ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Hackensack Meridian Health Medical Group - Primary Care Pc | 7911003330 | 273 |
News Archive
A mysterious, difficult-to-diagnose, and potentially deadly disease that was only recently discovered can be controlled most effectively if treatment is started within the first month that symptoms occur, according to a new report by researchers from the Perelman School of Medicine at the University of Pennsylvania.
Ohio's nursing home program in Medicaid - the federal-state health care program for the poor - is changing how nursing homes are paid to try to address their quality. In the meantime, ProPublica launches a nursing home inspection database.
Raptor Pharmaceutical Corp., announced positive findings from the completed treatment phase of its open-label Phase 2a clinical trial of delayed-release cysteamine bitartrate ("DR Cysteamine") in adolescent patients with non-alcoholic steatohepatitis ("NASH"), a progressive form of liver disease believed to affect 2% to 5% of the U.S. population.
A team of neuroengineers based at Brown University has developed a fully implantable and rechargeable wireless brain sensor capable of relaying real-time broadband signals from up to 100 neurons in freely moving subjects.
The national tobacco prevention strategy announced today by Health and Human Services Secretary Kathleen Sebelius provides a timely and much-needed shot in the arm for the nation's efforts to combat tobacco use, the number one cause of preventable death in America. It calls for bold and historic action that will improve health, save lives and save health care costs for employers, workers and taxpayers across the country.
› Verified 4 days ago
Entity Name | Hackensack Meridian Health Medical Group - Specialty Care Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1215989249 PECOS PAC ID: 9133032519 Enrollment ID: O20031111000524 |
News Archive
A mysterious, difficult-to-diagnose, and potentially deadly disease that was only recently discovered can be controlled most effectively if treatment is started within the first month that symptoms occur, according to a new report by researchers from the Perelman School of Medicine at the University of Pennsylvania.
Ohio's nursing home program in Medicaid - the federal-state health care program for the poor - is changing how nursing homes are paid to try to address their quality. In the meantime, ProPublica launches a nursing home inspection database.
Raptor Pharmaceutical Corp., announced positive findings from the completed treatment phase of its open-label Phase 2a clinical trial of delayed-release cysteamine bitartrate ("DR Cysteamine") in adolescent patients with non-alcoholic steatohepatitis ("NASH"), a progressive form of liver disease believed to affect 2% to 5% of the U.S. population.
A team of neuroengineers based at Brown University has developed a fully implantable and rechargeable wireless brain sensor capable of relaying real-time broadband signals from up to 100 neurons in freely moving subjects.
The national tobacco prevention strategy announced today by Health and Human Services Secretary Kathleen Sebelius provides a timely and much-needed shot in the arm for the nation's efforts to combat tobacco use, the number one cause of preventable death in America. It calls for bold and historic action that will improve health, save lives and save health care costs for employers, workers and taxpayers across the country.
› Verified 4 days ago
Entity Name | Hackensack Meridian Health Medical Group - Primary Care Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1336203538 PECOS PAC ID: 7911003330 Enrollment ID: O20070502000000 |
News Archive
A mysterious, difficult-to-diagnose, and potentially deadly disease that was only recently discovered can be controlled most effectively if treatment is started within the first month that symptoms occur, according to a new report by researchers from the Perelman School of Medicine at the University of Pennsylvania.
Ohio's nursing home program in Medicaid - the federal-state health care program for the poor - is changing how nursing homes are paid to try to address their quality. In the meantime, ProPublica launches a nursing home inspection database.
Raptor Pharmaceutical Corp., announced positive findings from the completed treatment phase of its open-label Phase 2a clinical trial of delayed-release cysteamine bitartrate ("DR Cysteamine") in adolescent patients with non-alcoholic steatohepatitis ("NASH"), a progressive form of liver disease believed to affect 2% to 5% of the U.S. population.
A team of neuroengineers based at Brown University has developed a fully implantable and rechargeable wireless brain sensor capable of relaying real-time broadband signals from up to 100 neurons in freely moving subjects.
The national tobacco prevention strategy announced today by Health and Human Services Secretary Kathleen Sebelius provides a timely and much-needed shot in the arm for the nation's efforts to combat tobacco use, the number one cause of preventable death in America. It calls for bold and historic action that will improve health, save lives and save health care costs for employers, workers and taxpayers across the country.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Ciro J Carafa, MD 4 Hunter St Ste 206, Lodi, NJ 07644-1608 Ph: (973) 473-3896 | Dr Ciro J Carafa, MD 120 S Main St, Lodi, NJ 07644-2204 Ph: (973) 473-7870 |
News Archive
A mysterious, difficult-to-diagnose, and potentially deadly disease that was only recently discovered can be controlled most effectively if treatment is started within the first month that symptoms occur, according to a new report by researchers from the Perelman School of Medicine at the University of Pennsylvania.
Ohio's nursing home program in Medicaid - the federal-state health care program for the poor - is changing how nursing homes are paid to try to address their quality. In the meantime, ProPublica launches a nursing home inspection database.
Raptor Pharmaceutical Corp., announced positive findings from the completed treatment phase of its open-label Phase 2a clinical trial of delayed-release cysteamine bitartrate ("DR Cysteamine") in adolescent patients with non-alcoholic steatohepatitis ("NASH"), a progressive form of liver disease believed to affect 2% to 5% of the U.S. population.
A team of neuroengineers based at Brown University has developed a fully implantable and rechargeable wireless brain sensor capable of relaying real-time broadband signals from up to 100 neurons in freely moving subjects.
The national tobacco prevention strategy announced today by Health and Human Services Secretary Kathleen Sebelius provides a timely and much-needed shot in the arm for the nation's efforts to combat tobacco use, the number one cause of preventable death in America. It calls for bold and historic action that will improve health, save lives and save health care costs for employers, workers and taxpayers across the country.
› Verified 4 days ago
Dr. Nora Z Tossounian, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 160 Essex St Ste 102, Lodi, NJ 07644 Phone: 551-996-8111 Fax: 551-996-8445 | |
Dr. Michael J. Matarese, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 116 Terrace Ave, Lodi, NJ 07644 Phone: 973-473-3896 | |
Tovah Tripp, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 160 Essex St Ste 102, Lodi, NJ 07644 Phone: 551-996-8111 Fax: 551-996-8445 | |
Dr. Maria Ann Ramos, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 147 Main St, Suite 6, Lodi, NJ 07644 Phone: 973-777-2888 Fax: 973-777-1088 | |
Dr. Prem Thamman, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 361 Garibaldi Ave, Lodi, NJ 07644 Phone: 973-773-3556 Fax: 973-773-2337 | |
Mauro Anthony Mecca, M.D. Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 1 S Main St, Lodi, NJ 07644 Phone: 973-778-3303 Fax: 973-778-3304 |